<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Prognosis of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> depends on many factors, such as age and sex of patient; location; multiplicity; local extent and size of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e>, or <z:mpath ids='MPATH_81'>perforation</z:mpath>; as well as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microscopic type and grade; vascular and perineural invasion; and nodal and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes strongly implicated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, hence in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to assess the role of MMP-2 and MMP-9 expression in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, invasion, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, hence their prognostic values </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: Immunohistochemical analysis of MMP-2 and MMP-9 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, an immunohistochemical score based on the intensity of immunoreactivity and proportion of immunoreactive cells that established for each MMP, and correlation of this expression with the established prognostic factors </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: MMP-2 was expressed in 81.8% (strong expression in 40%) of cases, and MMP-9 was expressed in 72% (strong expression in 35%) of cases </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: MMP-2 and MMP-9 are widely expressed in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, suggesting significant diagnostic and prognostic values in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Increased levels of MMP-2 and MMP-9 protein expression in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues as compared to <z:mpath ids='MPATH_458'>normal</z:mpath> tissues suggest their association with <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and that they could be targets for intervention and therapy in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>